先天性肾上腺增生症中胰岛素抵抗由胰岛素清除减少代偿
横断面研究纳入30例21-羟化酶缺陷型先天性肾上腺增生症(CAH)患者和21名对照,行高糖钳夹试验。CAH患者存在胰岛素抵抗,但β细胞分泌反应未代偿性增加,高胰岛素血症完全归因于胰岛素清除率降低约33%。结论提示肝脏胰岛素清除减少是维持糖稳态的代偿机制。
要点
- 21-OHD患者存在胰岛素抵抗,但β细胞分泌反应不能代偿。
- 高胰岛素血症完全由肝脏胰岛素清除率降低约33%所致。
- 肝脏清除减少作为门控机制调节胰岛素对敏感组织的暴露。
核心结论
- 21-OHD非肥胖患者胰岛素敏感性降低且β细胞反应不能代偿胰岛素抵抗,代偿性高胰岛素血症主要与肝脏胰岛素清除减少相关。
主要发现
- 21-OHD患者胰岛素抵抗增加。
- CAH患者系统性高胰岛素血症(肝后胰岛素输送)升高。
- 高糖钳夹第一时相及全程胰岛素分泌率(β细胞功能)未见增加。
- 胰岛素浓度升高完全归因于胰岛素清除率降低约33%。
临床怎么用
- 对21-OHD患者评估心血管代谢风险时,应关注胰岛素抵抗及代偿性高胰岛素血症。
- 高胰岛素血症可能反映肝脏胰岛素清除减少而非β细胞分泌增加,解读胰岛素水平时需考虑此机制。
局限性
- 横断面设计无法推断因果关系。
- 样本量较小(30例CAH患者)。
- 研究人群为年轻、非肥胖、糖耐量正常者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Congenital adrenal hyperplasia (CAH) patients have potential normal longevity. However, a greater risk for cardiovascular disease has been reported. Insulin resistance and hyperinsulinemia have been described in CAH patients, whereas the prevalence of overt type 2 diabetes is not higher in CAH than in normal population. OBJECTIVE: To examine the contributions of insulin secretion and of hepatic insulin clearance to compensatory hyperinsulinemia in young insulin-resistant adults with classic CAH due to 21-hydroxylase deficiency (21-OHD). DESIGN: Cross-sectional. SETTING: University outpatient clinics. METHODS: Fifty-one participants: 21 controls, and 30 CAH (15 virilizing and 15 salt-wasting phenotypes), female/male (33/18), age (mean [SD]): 24.0 (3.6) years, body mass index: 24.6 (4.9)kg/m2 with normal glucose tolerance, were submitted to a hyperglycemic clamp study. MAIN OUTCOME MEASURES: Insulin sensitivity, beta cell function, and hepatic insulin clearance using appropriate modeling. RESULTS: We found an increased insulin resistance in 21-OHD. The systemic hyperinsulinemia (posthepatic insulin delivery) was elevated in CAH patients. No increases were observed in insulin secretory rate (beta cell function) in the first phase or during the hyperglycemic clamp. The increase in insulin concentrations was totally due to a ~33% reduction in insulin clearance. CONCLUSION: 21-OHD nonobese subjects have reduced insulin sensitivity and beta cell response unable to compensate for the insulin resistance, probably due to overexposure to glucocorticoids. Compensatory hyperinsulinemia is most related with reduced hepatic insulin clearance. The exclusive adaptation of the liver acts as a gating mechanism to regulate the access of insulin to insulin-sensitive tissues to maintain glucose homeostasis.
引用
- de Oliveira DM, Tura A, Vasques ACJ, et al. Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance. J Clin Endocrinol Metab. 2021. PMID: 33421070. doi:10.1210/clinem/dgab010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。